Abstract:Background: The tight coupling between osteoblasts and osteoclasts is essential to maintain bone homeostasis. Deregulation of this process leads to loss and deterioration of the bone tissue causing diseases, such as osteoporosis. MicroRNAs are able to control bone-related mechanisms and have been explored as therapeutic tools. In this study, we investigated the potential of miR-99a-5p to modulate osteogenic differentiation, osteoclastogenesis, and the osteoblasts-osteoclasts crosstalk. Methods: To achieve this goal, human primary Mesenchymal Stem/Stromal Cells (MSC) were differentiated into osteoblasts and adipocytes, and miR-99a-5p expression was evaluated by RT-qPCR. Knockdown and overexpression experiments were conducted to modulate miR-99a-5p expression in MC3T3 cells. Cell proliferation and cell death/apoptosis were evaluated by resazurin assay and flow cytometry, respectively. Proteomic analysis was used to identify the miR-99a-5p regulatory network, and ELISA to evaluate OPG levels in the cell culture supernatant. Conditioned media from MC3T3-transfected cells was used to culture RAW 264.7 cells and the effect on osteoclast differentiation was assessed. Human primary monocytes were isolated to induce osteoclastogenesis and evaluate miR-99a-5p expression. Finally, levels of miR-99a-5p were modulated in RAW 264.7 cells to understand the impact on osteoclastogenesis. Results: The results show that miR-99a-5p is significantly downregulated during the early stages of human primary MSCs osteogenic differentiation and during MC3T3 osteogenic differentiation. On the other hand, miR-99a-5p levels are increased during the initial stages of adipogenic differentiation. Inhibition of miR-99a-5p in MC3T3 pre-osteoblastic cells promoted osteogenic differentiation, whereas its overexpression suppressed the levels of osteogenic specific genes (Runx2 and Alpl), as well as mineralization, with no effect on proliferation or apoptosis. Proteomic analysis of miR-99a-5p-transfected cells showed that numerous proteins known to be involved in cell differentiation were altered, including osteogenic differentiation markers and extracellular matrix proteins. While inhibition of miR-99a-5p increased the Tnfrsf11b (OPG encoding gene)/Tnfsf11 (RANKL encoding gene) mRNA expression ratio, in addition to increasing OPG secretion, miR-99a-5p overexpression resulted in the opposite effect. The cell culture supernatant of miR-99a-5p-inhibited MC3T3 cells impaired the osteoclastogenic potential of RAW 264.7 cells by decreasing the number of multinucleated cells and reducing the expression of osteoclastogenic markers. Interestingly, miR-99a-5p expression is increased during osteoclasts differentiation, both in human primary monocytes and RAW 264.7. These results show that miR-99a-5p per se is a positive regulator of osteoclastogenic differentiation. Conclusions: Globally, our findings show that miR-99a-5p inhibition promotes the commitment into osteogenic differentiation, impairs osteoclastogenic differentiation, and control bone cells communication. Ultimately, it supports miR-99a-5p as a target candidate for future miRNA-based therapies for bone diseases associated with bone remodeling deregulation.

Biological Functions of Mir-29B Contribute to Positive Regulation of Osteoblast Differentiation.

Hypoxia-Induced MicroRNA-429 Promotes Differentiation of MC3T3-E1 Osteoblastic Cells by Mediating ZFPM2 Expression

Mir-30 Family Members Negatively Regulate Osteoblast Differentiation*

TGF-(31-triggered (3 1-Triggered BMI1 and SMAD2 Cooperatively Regulate Mir-191 to Modulate Bone Formation

Mir-21 Synergizes with BMP9 in Osteogenic Differentiation by Activating the BMP9/Smad Signaling Pathway in Murine Multilineage Cells.

Mir-33-5p, a Novel Mechano-Sensitive Microrna Promotes Osteoblast Differentiation by Targeting Hmga2

Mir-342-3p Promotes Osteogenic Differentiation Via Targeting ATF3.

Downregulation of Mir-10b Promotes Osteoblast Differentiation Through Targeting Bcl6

miR-29cb2 promotes angiogenesis and osteogenesis by inhibiting HIF-3α in bone

Mir-218 Directs a Wnt Signaling Circuit to Promote Differentiation of Osteoblasts and Osteomimicry of Metastatic Cancer Cells

A Microrna Regulatory Mechanism of Osteoblast Differentiation

Circulating Micrornas, Mir-10B-5p, Mir-328-3p, Mir-100 and Let-7, Are Associated with Osteoblast Differentiation in Osteoporosis.

TGF-β1-triggered BMI1 and SMAD2 Cooperatively Regulate Mir-191 to Modulate Bone Formation

Silencing of Mir-330-5p Stimulates Osteogenesis in Bone Marrow Mesenchymal Stem Cells and Inhibits Bone Loss in Osteoporosis by Activating Bgn-mediated BMP/Smad Pathway.

The miR-29b/Matrix Metalloproteinase 2 Axis Regulates Transdifferentiation and Calcification of Vascular Smooth Muscle Cells in a Calcified Environment

miR-99a in bone homeostasis: Regulating osteogenic lineage commitment and osteoclast differentiation

Mir-143 Promotes Angiogenesis and Osteoblast Differentiation by Targeting HDAC7

A Runx2/Mir-3960/Mir-2861 Regulatory Feedback Loop During Mouse Osteoblast Differentiation

MicroRNA-495 Inhibits New Bone Regeneration Via Targeting High Mobility Group AT-Hook 2 (HMGA2)

Transcriptome Sequencing Profiling Identifies Mirna-331-3p As an Osteoblast-Specific Mirna in Infected Bone Nonunion

Inhibition of miR-29 Activity in the Myeloid Lineage Increases Response to Calcitonin and Trabecular Bone Volume in Mice